IRADIMED CORP IRMD
IRADIMED CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($17.02); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
IRADIMED CORP trades at about 49.9× earnings — near its 10-year norm (10-year range 15.2×–371.3×, median 52.7×).
Shaded band = 10-year range (15.2×–371.3×); dot = today's 49.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% | 77.1% | 76.3% | 75.9% | 81.1% |
| Operating margin | 31.2% | 30.0% | 30.6% | 29.3% | 23.5% | -2.4% | 22.5% | 19.7% | 5.6% | 33.6% |
| Net margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% | 25.0% | 20.7% | 2.2% | 22.2% |
| FCF margin | 20.5% | 24.1% | 9.2% | 17.3% | 25.8% | 16.9% | 25.6% | 23.5% | 11.4% | 26.5% |
| Return on assets | 20.7% | 19.6% | 18.7% | 15.0% | 11.3% | 1.9% | 14.4% | 13.0% | 1.3% | 19.4% |
| Return on equity | 23.8% | 22.2% | 24.1% | 17.4% | 12.9% | 2.2% | 17.3% | 15.0% | 1.5% | 22.6% |
| Current ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 | 12.96 | 10.06 | 9.50 | 8.61 | 9.25 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.